The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

TAVNEOS avacopan 10 mg hard capsule bottle (381053)

ARTG ID 381053

ARTG Name

TAVNEOS avacopan 10 mg hard capsule bottle

Product name

TAVNEOS avacopan 10 mg hard capsule bottle

ARTG Date

31 January 2023

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

avacopan

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

TAVNEOS avacopan 10 mg hard capsule bottle (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Seqirus Pty Ltd declaring $0 turnover in that period.
TAVNEOS avacopan 10 mg hard capsule bottle, Seqirus Pty Ltd, CON-1269

29 August 2024

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from 29 August 2024 until 1 September 2025.